$MEIP
MEI Pharma, Inc.

2017 Q2 Form 10-Q Financial Statement

#000119312517157424 Filed on May 04, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2017 Q1 2016 Q1
Revenue $449.0K $4.505M $0.00
YoY Change
Cost Of Revenue $990.0K $1.147M
YoY Change
Gross Profit -$540.0K $3.358M
YoY Change
Gross Profit Margin -120.27% 74.54%
Selling, General & Admin $1.830M $2.150M $1.990M
YoY Change -0.54% 8.04% -9.13%
% of Gross Profit 64.03%
Research & Development $2.070M $1.876M $3.420M
YoY Change -48.12% -45.15% -49.52%
% of Gross Profit 55.87%
Depreciation & Amortization $50.00K $10.00K $20.00K
YoY Change 400.0% -50.0% 0.0%
% of Gross Profit 0.3%
Operating Expenses $3.900M $1.876M $5.410M
YoY Change -32.99% -65.32% -39.62%
Operating Profit -$4.440M -$670.0K -$5.410M
YoY Change -87.62% -39.62%
Interest Expense $100.0K $70.00K $40.00K
YoY Change 100.0% 75.0% 33.33%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.340M -$600.0K -$5.370M
YoY Change -24.78% -88.83% -39.87%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.343M -$602.0K -$5.371M
YoY Change -24.73% -88.79% -39.85%
Net Earnings / Revenue -967.26% -13.36%
Basic Earnings Per Share -$0.12 -$0.02 -$0.16
Diluted Earnings Per Share -$0.12 -$0.02 -$0.16
COMMON SHARES
Basic Shares Outstanding 36.77M shares 37.17M shares 34.42M shares
Diluted Shares Outstanding 37.17M shares 34.42M shares

Balance Sheet

Concept 2017 Q2 2017 Q1 2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.60M $56.80M $49.40M
YoY Change 16.78% 14.98% -29.93%
Cash & Equivalents $8.458M $11.64M $14.29M
Short-Term Investments $45.10M $45.10M $35.10M
Other Short-Term Assets $1.800M $2.800M $1.100M
YoY Change 125.0% 154.55% 83.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $55.32M $59.52M $50.50M
YoY Change 18.34% 17.84% -28.98%
LONG-TERM ASSETS
Property, Plant & Equipment $50.00K $35.00K $53.00K
YoY Change 2.04% -33.96% -31.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $381.0K $375.0K $427.0K
YoY Change -8.19% -12.18% -12.14%
TOTAL ASSETS
Total Short-Term Assets $55.32M $59.52M $50.50M
Total Long-Term Assets $381.0K $375.0K $427.0K
Total Assets $55.70M $59.89M $50.93M
YoY Change 18.11% 17.59% -28.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $585.0K $242.0K $466.0K
YoY Change -45.78% -48.07% -82.81%
Accrued Expenses $3.285M $3.711M $3.559M
YoY Change -25.9% 4.27% -9.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.866M $4.989M $4.025M
YoY Change -11.72% 23.95% -39.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.866M $4.989M $4.025M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $4.866M $5.000M $4.000M
YoY Change -11.72% 25.0% -39.39%
SHAREHOLDERS EQUITY
Retained Earnings -$174.3M -$170.0M -$171.2M
YoY Change -1.51% -0.73% 13.79%
Common Stock $225.2M $224.9M $218.1M
YoY Change 2.98% 3.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $50.84M $54.90M $46.91M
YoY Change
Total Liabilities & Shareholders Equity $55.70M $59.89M $50.93M
YoY Change 18.11% 17.59% -28.87%

Cashflow Statement

Concept 2017 Q2 2017 Q1 2016 Q1
OPERATING ACTIVITIES
Net Income -$4.343M -$602.0K -$5.371M
YoY Change -24.73% -88.79% -39.85%
Depreciation, Depletion And Amortization $50.00K $10.00K $20.00K
YoY Change 400.0% -50.0% 0.0%
Cash From Operating Activities -$3.140M $1.600M -$4.380M
YoY Change -10.03% -136.53% -46.26%
INVESTING ACTIVITIES
Capital Expenditures -$50.00K $0.00 $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $10.00K -$5.020M $5.010M
YoY Change -66.67% -200.2% 0.2%
Cash From Investing Activities -$40.00K -$5.010M $5.000M
YoY Change -233.33% -200.2% 0.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -3.140M 1.600M -4.380M
Cash From Investing Activities -40.00K -5.010M 5.000M
Cash From Financing Activities 0.000 0.000 0.000
Net Change In Cash -3.180M -3.410M 620.0K
YoY Change -8.09% -650.0% -119.44%
FREE CASH FLOW
Cash From Operating Activities -$3.140M $1.600M -$4.380M
Capital Expenditures -$50.00K $0.00 $0.00
Free Cash Flow -$3.090M $1.600M -$4.380M
YoY Change -11.46% -136.53% -46.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
36772428 shares
CY2012Q3 meip Milestone Payments Maximum Amount
MilestonePaymentsMaximumAmount
75200000
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14291000
CY2017Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
113000000 shares
CY2017Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36772428 shares
CY2017Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00000002
CY2017Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36772428 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2017037 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.54
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4266292 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.21
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-169988000
CY2017Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
59891000
CY2017Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1036000
CY2017Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
242000
CY2017Q1 us-gaap Stockholders Equity
StockholdersEquity
54902000
CY2017Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
86000
CY2017Q1 us-gaap Common Stock Value
CommonStockValue
0
CY2017Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
224890000
CY2017Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4989000
CY2017Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3711000
CY2017Q1 us-gaap Assets Current
AssetsCurrent
59516000
CY2017Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35000
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
81367
CY2017Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11644000
CY2017Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
56760000
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
0
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
218653000
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q3 us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
195756 shares
CY2017Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1400000
CY2017Q1 us-gaap Short Term Investments
ShortTermInvestments
45116000
CY2017Q1 us-gaap Assets
Assets
59891000
CY2017Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
340000
CY2017Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2756000
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
467597
CY2017Q1 meip Shelf Registration Statement Value
ShelfRegistrationStatementValue
104000000
CY2017Q1 meip Accrued Milestone Payments
AccruedMilestonePayments
700000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18722000
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
113000000 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34155997 shares
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00000002
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34155997 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2827172 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.29
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-177001000
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47164000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1079000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
41652000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5512000
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4433000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
46749000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10837000
CY2016Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
45918000
CY2016Q2 us-gaap Short Term Investments
ShortTermInvestments
35081000
CY2016Q2 us-gaap Assets
Assets
47164000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
366000
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
831000
CY2012Q3 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
500000
CY2012Q3 meip Upfront And Milestone Payments
UpfrontAndMilestonePayments
200000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7583217 shares
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Type
DocumentType
10-Q
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
dei Entity Central Index Key
EntityCentralIndexKey
0001262104
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
6632000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
54630 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M12D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.15
dei Trading Symbol
TradingSymbol
MEIP
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36760754 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36693940 shares
dei Amendment Flag
AmendmentFlag
false
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.012 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
33333 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.12
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.36
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.37
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
36323624 shares
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6802000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Period End Date
DocumentPeriodEndDate
2017-03-31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
66814 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1527083 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. The Company uses estimates that affect the reported amounts (including assets, liabilities, revenues and expenses) and related disclosures. Actual results could materially differ from those estimates.</p> </div>
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
1920000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
50110000
us-gaap Operating Income Loss
OperatingIncomeLoss
6822000
us-gaap Net Income Loss
NetIncomeLoss
7013000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
192000
us-gaap Licenses Revenue
LicensesRevenue
20880000
dei Entity Registrant Name
EntityRegistrantName
MEI Pharma, Inc.
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.082 pure
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
370316 shares
us-gaap Revenues
Revenues
22800000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1925000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
42000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-837000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-10037000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4212000
us-gaap Share Based Compensation
ShareBasedCompensation
2025000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1036000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
40075000
us-gaap Costs And Expenses
CostsAndExpenses
15978000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-397000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
9943000
us-gaap Share Based Compensation
ShareBasedCompensation
2207000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
50136000
us-gaap Costs And Expenses
CostsAndExpenses
15183000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-722000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
29000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
4212000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5164000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
807000
us-gaap Cost Of Services
CostOfServices
4012000
meip Shelf Registration Expiration Date
ShelfRegistrationExpirationDate
2017-04
meip Lease Arrangement Rent Area
LeaseArrangementRentArea
8800 sqft
meip Lease Expiration Month And Year
LeaseExpirationMonthAndYear
2017-06
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6554186 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14374000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34393087 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34393087 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.017 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.35
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
34155997 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.168 pure
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
237090 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
40190000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15183000
us-gaap Net Income Loss
NetIncomeLoss
-15092000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
92000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
600000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
45000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5765000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-537000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9418000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4431000
CY2012Q3 meip Agreement Termination Notice Period
AgreementTerminationNoticePeriod
P90D
CY2012Q3 meip Percentage Of Purchases From Major Suppliers
PercentageOfPurchasesFromMajorSuppliers
1.00 pure
CY2017Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8069528 shares
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37172428 shares
CY2016Q1 us-gaap Costs And Expenses
CostsAndExpenses
5410000
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1990000
CY2016Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3420000
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37172428 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
36772428 shares
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2017Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
400000 shares
CY2017Q1 us-gaap Revenues
Revenues
4505000
CY2017Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
726000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-670000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-602000
CY2017Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
68000
CY2017Q1 us-gaap Licenses Revenue
LicensesRevenue
3779000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
614000
CY2017Q1 us-gaap Costs And Expenses
CostsAndExpenses
5175000
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2152000
CY2017Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1876000
CY2017Q1 us-gaap Cost Of Services
CostOfServices
1147000
CY2016Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6694158 shares
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34422663 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34422663 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
34155997 shares
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2016Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
266666 shares
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5410000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-5371000
CY2016Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
39000
CY2016Q1 us-gaap Share Based Compensation
ShareBasedCompensation
639000

Files In Submission

Name View Source Status
0001193125-17-157424-index-headers.html Edgar Link pending
0001193125-17-157424-index.html Edgar Link pending
0001193125-17-157424.txt Edgar Link pending
0001193125-17-157424-xbrl.zip Edgar Link pending
d331257d10q.htm Edgar Link pending
d331257dex31.htm Edgar Link pending
d331257dex311.htm Edgar Link pending
d331257dex312.htm Edgar Link pending
d331257dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
meip-20170331.xml Edgar Link completed
meip-20170331.xsd Edgar Link pending
meip-20170331_cal.xml Edgar Link unprocessable
meip-20170331_def.xml Edgar Link unprocessable
meip-20170331_lab.xml Edgar Link unprocessable
meip-20170331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending